Gene expression profiling of ovarian cancer reveals candidate diagnostic and prognostic biomarkers: An integrated bioinformatics approach
Cancer Biomarkers · 2026-06 · 43
DOI: 10.1177/18758592261468586 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biomarkers, online erschienen am 14.07.2026. Verfasst von Michael Woode und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology & Biotechnology, University of Cape Coast, Cape Coast, Ghana. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Biomarkers, Tumor, Gene Expression Profiling, Computational Biology. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Ovarian cancer remains one of the most lethal gynecological malignancies, largely due to delayed diagnosis and limited effectiveness of current biomarkers. Identifying candidate biomarkers through integrated gene expression analysis may enhance understanding of OC biology and support future diagnostic and prognostic investigations.
Methods
Four microarray datasets were retrieved from the Gene Expression Omnibus and analyzed using the limma package in R to identify differentially expressed genes (DEGs) through a bidirectional filter (|log 2 FC| ≥ 1.2). Overlapping DEGs across all four datasets were subjected to Gene Ontology and KEGG pathway enrichment analyses. Protein-protein interaction networks were constructed using the STRING database, and hub genes were identified by consensus across three centrality algorithms in Cytoscape. Prognostic significance was evaluated using Kaplan-Meier survival analysis via GEPIA2; diagnostic performance was assessed using Youden Index-based ROC analysis; and external validation was performed using an independent dataset.
Results
A total of 209 overlapping DEGs were identified, yielding 35 hub genes. Functional enrichment analysis implicated cell cycle dysregulation, metabolic reprogramming, and extracellular matrix remodeling as central biological processes. TRIP13, FGF13, and LYVE1 were significantly associated with overall survival, while ALDH1A1, GATA6, and WNT5A were associated with disease-free survival. KDR demonstrated the highest diagnostic accuracy, and external validation confirmed the generalizability of the diagnostic findings.
Conclusion
This study identifies a panel of candidate diagnostic and prognostic biomarkers in ovarian cancer, providing a molecular framework for future experimental validation and translational investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology & Biotechnology, University of Cape Coast, Cape Coast, Ghana.
- Department of Biomedical Sciences, University of Cape Coast, Cape Coast, Ghana.
- Department of Forensic Sciences, University of Cape Coast, Cape Coast, Ghana.
ORCID-Profile: Michael Woode, Mark Akuamoah Appah, Du-Bois Asante
Zitieren
APA
Woode, M., Appah, M. A., Alhassan, E. K., Makwo, T., Asante, D. B., & Agyirifo, D. S. (2026). Gene expression profiling of ovarian cancer reveals candidate diagnostic and prognostic biomarkers: An integrated bioinformatics approach. Cancer Biomarkers, 43. https://doi.org/10.1177/18758592261468586
Vancouver
Woode M, Appah MA, Alhassan EK, Makwo T, Asante DB, Agyirifo DS. Gene expression profiling of ovarian cancer reveals candidate diagnostic and prognostic biomarkers: An integrated bioinformatics approach. Cancer Biomarkers. 2026;43. doi:10.1177/18758592261468586
BibTeX
@article{Woode2026,
author = {Woode, Michael and Appah, Mark Akuamoah and Alhassan, Emmanuel Kpalakuso and Makwo, Timothy and Asante, Du-Bois and Agyirifo, Daniel Sakyi},
title = {Gene expression profiling of ovarian cancer reveals candidate diagnostic and prognostic biomarkers: An integrated bioinformatics approach},
journal = {Cancer Biomarkers},
year = {2026},
volume = {43},
doi = {10.1177/18758592261468586}
}
EUVIMED